内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

AMICUS THERAPEUTICS, INC.

FOLD · — · CIK 0001178879 · Healthcare

内部人信号

当前没有活跃买入信号

0 qualifying P purchase groups
当前 180 天评分窗口

15 同一窗口内观察到的 Form 4 交易行
0 sales · 15 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2021-11-01 · WHITMAN BURKE W · $15.7K

为什么没有活跃信号？

买入活动无
近期买入无
近期卖出无
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数？

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。

卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
WHITMAN BURKE WDirector
○
WHEELER CRAIG ADirector
○
SBLENDORIO GLENNDirector
○
ROBERTS EIRYDirector
○
RAAB MICHAELDirector
○
Prout SamanthaChief Accounting Officer
○
● 买入▼ 卖出○ 其他

Showing the six most active owners; 8 additional owner(s) remain in Form 4 申报证据.

买方广度、集中度与聚集买入

合资格买入进入 180 天研究窗口后，这些模块才会启用。

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2021-11-01 · WHITMAN BURKE W.

近期 Form 4 活动

0买入
13卖出
35其他 Form 4 交易行
32SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他15 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

FINRA 报告中没有该股票代码的空头余额。

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2021-11-01WHITMAN BURKE W买入 (P)Common Stock1,500USD 10.49USD 15,735SEC 申报 ↗
2021-10-01WHITMAN BURKE W买入 (P)Common Stock1,500USD 9.56USD 14,340SEC 申报 ↗
2021-09-01WHITMAN BURKE W买入 (P)Common Stock1,500USD 11.41USD 17,115SEC 申报 ↗
2021-08-02WHITMAN BURKE W买入 (P)Common Stock1,500USD 9.28USD 13,920SEC 申报 ↗
2021-07-01WHITMAN BURKE W买入 (P)Common Stock1,500USD 9.60USD 14,400SEC 申报 ↗
2021-06-01WHITMAN BURKE W买入 (P)Common Stock1,500USD 9.24USD 13,860SEC 申报 ↗
2021-05-25Bleil Lynn Dorsey买入 (P)Common Stock28,605USD 8.74USD 250,008SEC 申报 ↗
2021-05-03WHITMAN BURKE W买入 (P)Common Stock1,500USD 10.21USD 15,315SEC 申报 ↗
2021-04-01WHITMAN BURKE W买入 (P)Common Stock1,500USD 10.00USD 15,000SEC 申报 ↗
2021-03-01WHITMAN BURKE W买入 (P)Common Stock1,500USD 12.40USD 18,600SEC 申报 ↗
2021-02-01WHITMAN BURKE W买入 (P)Common Stock1,500USD 19.09USD 28,635SEC 申报 ↗
2021-01-04WHITMAN BURKE W买入 (P)Common Stock1,500USD 23.17USD 34,755SEC 申报 ↗
2020-12-01WHITMAN BURKE W买入 (P)Common Stock1,500USD 23.50USD 35,250SEC 申报 ↗
2020-11-02WHITMAN BURKE W买入 (P)Common Stock1,500USD 18.01USD 27,015SEC 申报 ↗
2020-10-01WHITMAN BURKE W买入 (P)Common Stock1,500USD 14.28USD 21,420SEC 申报 ↗

Form 4 申报证据

48 transaction lines in the latest 365-day window; 794 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-04-27WHITMAN BURKE WD (D)Common Stock118,598USD 14.50USD 1,719,671SEC 申报 ↗
2026-04-27WHEELER CRAIG AD (D)Common Stock84,631USD 14.50USD 1,227,150SEC 申报 ↗
2026-04-27SBLENDORIO GLENND (D)Common Stock142,564USD 14.50USD 2,067,178SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-04-27WHITMAN BURKE WD (D)Common Stock118,598USD 14.50USD 1,719,671SEC 申报 ↗
2026-04-27WHEELER CRAIG AD (D)Common Stock84,631USD 14.50USD 1,227,150SEC 申报 ↗
2026-04-27SBLENDORIO GLENND (D)Common Stock142,564USD 14.50USD 2,067,178SEC 申报 ↗
2026-04-27Rosenberg EllenD (D)Common Stock478,898USD 14.50USD 6,944,021SEC 申报 ↗
2026-04-27ROBERTS EIRYD (D)Common Stock76,275USD 14.50USD 1,105,988SEC 申报 ↗
2026-04-27RAAB MICHAELD (D)Common Stock115,857USD 14.50USD 1,679,926SEC 申报 ↗
2026-04-27Prout SamanthaD (D)Common Stock125,951USD 14.50USD 1,826,290SEC 申报 ↗
2026-04-27MCGLYNN MARGARET GD (D)Common Stock94,631USD 14.50USD 1,372,150SEC 申报 ↗
2026-04-27Kelly Michael AaronD (D)Common Stock72,468USD 14.50USD 1,050,786SEC 申报 ↗
2026-04-27Harford Simon N.R.D (D)Common Stock143,595USD 14.50USD 2,082,128SEC 申报 ↗
2026-04-27Clark David MichaelD (D)Common Stock221,811USD 14.50USD 3,216,260SEC 申报 ↗
2026-04-27Castelli JeffD (D)Common Stock427,089USD 14.50USD 6,192,790SEC 申报 ↗
2026-04-27Campbell Bradley LD (D)Common Stock1,008,680USD 14.50USD 14,625,860SEC 申报 ↗
2026-04-27Bleil Lynn DorseyD (D)Common Stock113,941USD 14.50USD 1,652,144SEC 申报 ↗
2026-03-02Campbell Bradley L卖出 (S)Common Stock22,500USD 14.35USD 322,875SEC 申报 ↗
2026-01-20Campbell Bradley L卖出 (S)Common Stock75,000USD 14.31USD 1,073,250SEC 申报 ↗
2026-01-20Campbell Bradley L期权行权／转换 (M)Common Stock75,000USD 6.10USD 457,500SEC 申报 ↗
2026-01-03Rosenberg Ellen代扣税 (F)Common Stock29,683USD 14.27USD 423,576SEC 申报 ↗
2026-01-03Prout Samantha代扣税 (F)Common Stock12,240USD 14.27USD 174,665SEC 申报 ↗
2026-01-03Clark David Michael代扣税 (F)Common Stock18,498USD 14.27USD 263,966SEC 申报 ↗
2026-01-03Castelli Jeff代扣税 (F)Common Stock23,102USD 14.27USD 329,666SEC 申报 ↗
2026-01-02Rosenberg Ellen代扣税 (F)Common Stock13,426USD 14.27USD 191,589SEC 申报 ↗
2026-01-02Prout Samantha代扣税 (F)Common Stock3,443USD 14.27USD 49,132SEC 申报 ↗
2026-01-02Clark David Michael代扣税 (F)Common Stock5,381USD 14.27USD 76,787SEC 申报 ↗
2026-01-02Castelli Jeff代扣税 (F)Common Stock6,905USD 14.27USD 98,534SEC 申报 ↗
2025-12-26Harford Simon N.R.代扣税 (F)Common Stock71,303USD 14.25USD 1,016,068SEC 申报 ↗
2025-12-26Campbell Bradley L代扣税 (F)Common Stock108,602USD 14.25USD 1,547,578SEC 申报 ↗
2025-12-19Clark David Michael卖出 (S)Common Stock25,642USD 14.17USD 363,347SEC 申报 ↗
2025-12-15Clark David Michael卖出 (S)Common Stock25,643USD 11.00USD 282,073SEC 申报 ↗
2025-12-15Campbell Bradley L卖出 (S)Common Stock77,926USD 10.86USD 846,276SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码FOLD
CIK0001178879
行业Healthcare
细分行业— Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所—

数据覆盖

本地 Form 4 历史794 transaction lines from 2020-01-02 to 2026-04-27
19 P purchase lines · 255 S sale lines · 520 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.